Australia markets open in 4 hours 57 minutes

NewAmsterdam Pharma Company N.V. (NAMS)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
22.89+0.92 (+4.16%)
As of 03:01PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 1.96B
Enterprise value 1.62B
Trailing P/E 29.99
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)128.05
Price/book (mrq)6.80
Enterprise value/revenue 114.97
Enterprise value/EBITDA -9.16

Trading information

Stock price history

Beta (5Y monthly) 0.02
52-week change 357.49%
S&P500 52-week change 323.57%
52-week high 326.35
52-week low 35.63
50-day moving average 321.61
200-day moving average 314.27

Share statistics

Avg vol (3-month) 3222.75k
Avg vol (10-day) 3139.38k
Shares outstanding 589.27M
Implied shares outstanding 689.27M
Float 829.58M
% held by insiders 15.77%
% held by institutions 176.19%
Shares short (15 Apr 2024) 4335.21k
Short ratio (15 Apr 2024) 41.98
Short % of float (15 Apr 2024) 40.76%
Short % of shares outstanding (15 Apr 2024) 40.38%
Shares short (prior month 15 Mar 2024) 4344.63k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-2,777.93%

Management effectiveness

Return on assets (ttm)-27.70%
Return on equity (ttm)-49.26%

Income statement

Revenue (ttm)14.09M
Revenue per share (ttm)0.17
Quarterly revenue growth (yoy)27.20%
Gross profit (ttm)N/A
EBITDA -182.92M
Net income avi to common (ttm)-176.94M
Diluted EPS (ttm)-2.15
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)340.45M
Total cash per share (mrq)3.81
Total debt (mrq)60k
Total debt/equity (mrq)0.02%
Current ratio (mrq)6.95
Book value per share (mrq)3.50

Cash flow statement

Operating cash flow (ttm)-141.22M
Levered free cash flow (ttm)-72M